A project on biopharmaceutical research center is discussed in Novosibirsk

| By | Biological engineering, Biotechnologies, Drug Development
News

Novosibirsk region may become one of the leading federal centers for development of science and engineering in the area of biotechnology to attract investments in biotech.

Since Novosibirsk region has numerous scientific, manufacturing and labor competences related to all major branches of biotech (industrial, agricultural, medical, and pharmaceutical), it is already implementing a number of significant projects in the area of medical and industrial biotechnology.

In particular, a consortium between the Institute of Chemical Biology and Fundamental Medicine (ICBFM) of Siberian Branch of RAS and Novosibirsk State University (NSU) is developing product lines based on advanced technology for recombinant antibodies, nucleic acid drugs, and vaccines. Joint ventures with leading Russian pharmaceutical companies were established to launch the products in the market.

The next stage in the area of biopharmaceuticals will include the development of engineering to design new drugs in partnership with major Russian manufacturers. Currently, the project to establish a research and engineering center in ICBFM is discussed with the Russian Federal Agency for Scientific Organizations (FASO).

A land plot near the city of Berdsk with the necessary infrastructure for building a large-scale facility for several production lines was suggested as an area for developing a biotech industrial cluster.